NVO catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
December 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 14, 2026Sponsor estimate | NCT07184632A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityNovo Nordisk A/S · Overweight | NVOLead | Phase 2 | Active, not recruiting | Locked | Locked | Locked |
| Dec 28, 2026Sponsor estimate | NCT07739901Korean Real-world Study on MASLD/MASH Outcomes.Novo Nordisk A/S · MASLD/MASH | NVOLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Dec 31, 2026Sponsor estimate | NCT05230550Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®Novo Nordisk A/S · Adult Growth Hormone Deficiency | NVOLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
- Primary completion Dec 14, 2026Sponsor estimatePhase 2NCT07184632A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityNovo Nordisk A/S · OverweightActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 28, 2026Sponsor estimateNo phase registeredNCT07739901Korean Real-world Study on MASLD/MASH Outcomes.Novo Nordisk A/S · MASLD/MASHActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT05230550Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®Novo Nordisk A/S · Adult Growth Hormone DeficiencyActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
January 2027
- Primary completion Jan 19, 2027Sponsor estimatePhase 1NCT06859073A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaNovo Nordisk A/S · Healthy VolunteersActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 20, 2027Sponsor estimateNo phase registeredNCT07160816A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood SugarNovo Nordisk A/S · Diabetes Mellitus, Type 1Active, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 25, 2027Sponsor estimatePhase 3NCT07076199A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both...Novo Nordisk A/S · Diabetes Mellitus, Type 1Active, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 29, 2027Sponsor estimatePhase 3NCT06118281ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackNovo Nordisk A/S · Cardiovascular RiskActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.